FDA DEVICE FACTS
OPRA Implant System
Integrum AB
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The OPRATM Implant System is indicated for patients who have transfemoral amputation due to trauma or cancer and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis. The OPRATM Implant System is intended for skeletally mature patients.
The patient failed to receive benefit from socket prostheses or is expected to not tolerate socket use due to problems such as:
• Recurrent skin infections and ulcerations in the socket contact area
• Pain
• A short stump preventing the use of socket prosthesis
• Volume fluctuation in the stump
• Soft tissue scarring
• Extensive area of skin grafting
• Socket retention problems due to excessive perspiration
• Restricted mobility
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。